|
|
|
|
| LEADER |
02190nmm a2200301 u 4500 |
| 001 |
EB001419677 |
| 003 |
EBX01000000000000000911681 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
170502 ||| eng |
| 020 |
|
|
|a 9781493966974
|
| 100 |
1 |
|
|a Tan, Puay Hoon
|
| 245 |
0 |
0 |
|a Atlas of Differential Diagnosis in Breast Pathology
|h Elektronische Ressource
|c by Puay Hoon Tan, Aysegul A. Sahin
|
| 250 |
|
|
|a 1st ed. 2017
|
| 260 |
|
|
|a New York, NY
|b Springer New York
|c 2017, 2017
|
| 300 |
|
|
|a XX, 625 p. 1012 illus., 998 illus. in color
|b online resource
|
| 505 |
0 |
|
|a Normal Breast and Physiological Changes -- Developmental, Reactive, and Inflammatory Conditions -- Fibroepithelial Lesions -- Papillary Lesions -- Benign Sclerosing Lesions -- Mucinous Lesions -- Apocrine Lesions -- Vascular Lesions -- Intraductal Proliferative Lesions -- Lobular Lesions (Lobular Neoplasia, Invasive Lobular Carcinoma) -- Spindle Cell Lesions -- Invasive Carcinoma -- Nipple Lesions -- Male Breast Lesions -- Treatment-Related Changes
|
| 653 |
|
|
|a Pathology
|
| 653 |
|
|
|a Oncology
|
| 653 |
|
|
|a Oncology
|
| 653 |
|
|
|a Pathology
|
| 700 |
1 |
|
|a Sahin, Aysegul A.
|e [author]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 490 |
0 |
|
|a Atlas of Anatomic Pathology
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4939-6697-4?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.07
|
| 520 |
|
|
|a This atlas illustrates the range of breast lesions and their differential diagnoses, with pictorial correlation of gross and microscopic features. Where relevant, radiological images are incorporated. A description of normal, developmental and physiological breast morphology will serves as introduction to the main content of this atlas. Classification of tumors is based on the latest World Health Organisation Classification of Tumors of the Breast, 4th edition, 2012. As immunohistochemistry is a key adjunctive platform in the workup of breast lesions as well as used in prognostic evaluation of breast cancers, appropriate examples are interspersed. Molecular tools used in corroborating diagnoses and a discussion of therapy related changes are included.
|